Skip to main content
. 2015 Apr 16;11:621–632. doi: 10.2147/TCRM.S67387

Figure 2.

Figure 2

General recommendations for the treatment of type 2 diabetes from the American Diabetes Association/European Association for the Study of Diabetes.

Notes: aOrder of drugs does not denote any specific preference; busually basal insulin. Copyright © 2009. American Diabetes Association. Adapted with permission from Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140–149.124

Abbreviations: DPP-4i, dipeptidyl peptidase-4 inhibitor; GLP-1 RA, glucagon-like peptide-1 receptor agonist; A1C, glycated hemoglobin; Met, metformin; SGLT2i, sodium-glucose co-transporter 2 inhibitor; SU, sulfonylurea; TZD, thiazolidinedione.